Natco Pharma receives Establishment Inspection Report for Kothur facity
On successful closure of USFDA inspection
Natco Pharma has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for the pre-approval inspection conducted at its drug formulations facility in Kothur village, Telangana, India, during the period from 2 March to 6 March, 2020.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 25 2020 | 11:36 AM IST